Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Baxter
AstraZeneca
Boehringer Ingelheim
Express Scripts

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

Formulation information for generic ingredient: IDELALISIB


Email this page to a colleague

« Back to Dashboard

Idelalisib

CASRN: 870281-82-6

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Boehringer Ingelheim
Harvard Business School
Johnson and Johnson
McKesson